Back to Business

Barclays cuts Cellectis stock rating on gene editing concerns

Business September 16, 2026 at 8:36 AM

Barclays cuts Cellectis stock rating on gene editing concerns

Investing.com

Read at Investing.com

More Stories

I quit my Google software engineering job and became a watercolor artist. Here’s how I’m using — and not using — AI.

I quit my Google software engineering job and became a watercolor artist. Here’s how I’m using — and…

Watercolor artist Sara Wilczynska explains how she uses AI to help her with her business — and where she draws the line …

🇺🇸 Business Insider 29m ago

Goldman's investment banking chief shares how she uses AI most — and how juniors should use it to get ahead

Goldman's investment banking chief shares how she uses AI most — and how juniors should use it to ge…

Posnett said junior employees need to strike a balance with their AI usage. Bloomberg/Getty Images Kim Posnett, co-head …

🇺🇸 Business Insider 32m ago

Montana Senate candidate who shot a stand-in Flock camera in a campaign ad calls for federal limits on surveillance tech

Montana Senate candidate who shot a stand-in Flock camera in a campaign ad calls for federal limits …

Seth Bodnar, who is running for US Senate in Montana, called for federal regulation on surveillance tech. William Campbe…

🇺🇸 Business Insider 33m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play